This compound is primarily utilized in the field of pharmaceutical research and development, particularly in the study of neurological disorders. It serves as a key intermediate in the synthesis of potential therapeutic agents targeting conditions such as epilepsy, neuropathic pain, and other central nervous system ailments. Its deuterated form (d3) is especially valuable in drug metabolism studies, as it allows researchers to track and analyze the metabolic pathways of the compound with greater precision using techniques like mass spectrometry. Additionally, it is employed in the development of radiolabeled tracers for imaging studies, aiding in the understanding of disease mechanisms and the evaluation of drug efficacy in preclinical models.